Src family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells

Molecular Endocrinology

Volumn 23, Issue 2, 2009, Pages 202-212

  Piazza, Timothy M ^a   Lu, Juu Chin ^a   Carver, Kristopher C ^a,b   Schuler, Linda A ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMIN II; GUANOSINE TRIPHOSPHATASE; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROLACTIN RECEPTOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; DYNAMIN II; ENDOCYTOSIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; JANUS KINASE 2; MEMBRANE MICRODOMAINS; PROTEIN ISOFORMS; RECEPTORS, PROLACTIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 58849151470     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0341     Document Type: Article

References (68)

1. Goffin V, Binart N, Touraine P, Kelly PA 2002 Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47-67
2. Freeman ME, Kanyicska S, Lerant A, Nagy G 2000 Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523-1631
3. Tworoger SS, Hankinson SE 2006 Prolactin and breast cancer risk. Cancer Lett 243:160-169
4. Arendt LM, Schuler LA 2008 Transgenic models to study actions of prolactin in mammary neoplasia. J Mammary Gland Biol Neopl 13:29-40
5. Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV 1997 Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 138:5555-5560
6. Mertani HC, Garcia-Caballero T, Lambert A, Gérard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE,Morel G 1998 Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer 79:202-211
7. Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, Nicolas A, Trivin C, Postel-Vinay MC, KuttennF, Kelly PA 1998 Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab 83:667-674
8. Meng JP, Tsai-Morris CH, Dufau ML 2004 Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human pro-lactin receptor associated with mammary carcinoma. Cancer Res 64:5677-5682
9. Clevenger CV, Furth PA, Hankinson SE, Schuler LA 2003 Role of prolactin in mammary carcinoma. Endocr Rev 24:1-27
10. Swaminathan G, Varghese B, Fuchs SY 2008 Regulation of prolactin receptor levels and activity in breast cancer. J Mammary Gland Biol Neoplasia 13: 81-91
11. Fresno Vara JA, Carretero MV, Geronimo H, Ballmer-Hofer K, Martin-Perez J 2000 Stimulation of c-Src by prolactin is independent of Jak2. Biochem J 345:17-24
12. Acosta JJ, Munoz RM, Gonzalez L, Subtil-Rodriguez A, Dominguez-Caceres MA, Garcia-Martinez JM, Calcabrini A, Lazaro-Trueba I, Martin-Perez J 2003 Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Mol Endocrinol 17:2268-2282
13. Gutzman JH, Rugowski DE, Nikolai SE, Schuler LA 2007 Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin initiated signals in tumorigenesis dependent on cell context. Oncogene 26:6341-6348
14. Canbay E, Norman M, Kilic E, Goffin V, Zachary I 1997 Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells. Biochem J324:231-236
15. Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H 2005 Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 24:746-760
16. Arendt LM, Rose-Hellekant TA, Sandgren EP, Schuler LA 2006 Prolactin potentiates TGFα induction of mammary neoplasia in transgenic mice. Am J Pathol 168:1365-1374
17. Lu J-C, Piazza TM, Schuler LA 2005 Proteasomes mediate prolactin-induced receptor downregulation and fragment generation in breast cancer cells. J Biol Chem 280:33909-33916
18. Walrafen P, Verdier F, Kadri Z, Chretien S, Lacombe C, Mayeux P 2005 Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood 105:600-608
19. Martinez-Moczygemba M, Huston DP 2001 Proteasomal regulation of βc signaling reveals a novel mechanism for cytokine receptor heterotypic desen-sitization. J Clin Invest 108:1797-1806
20. Le Roy C, Wrana JL 2005 Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 6:112-126
21. Chini B, Parenti M 2004 G-protein coupled receptors in lipid rafts and caveo-lae: how, when and why do they go there? J Mol Endocrinol 32:325-338
22. Cohen AW, Combs TP, Scherer PE, Lisanti MP 2003 Role of caveolin and caveolae in insulin signaling and diabetes. Am J Physiol Endocrinol Metab 285:E1151-E1160
23. Swaminathan G, Varghese B, Thangavel C, Carbone CJ, PlotnikovA, Kumar KG, Jablonski EM, Clevenger CV, Goffin V, Deng L, Frank SJ, Fuchs SY 2008 Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J Endocrinol 196:R1-R7
24. Deng L, He K, Wang XD, Yang N, Thangavel C, Jiang J, Fuchs SY, Frank SJ 2007 Determinants of growth hormone receptor down-regulation. Mol En-docrinol 21:1537-1551
25. Marijanovic Z, Ragimbeau J, Kumar KGS, Fuchs SY, Pellegrini S 2006 TYK2 activity promotes ligand-induced IFNAR1 proteolysis. Biochem J 397:31-38
26. Meyer L, Deau B, Forejtnikova H, Dumenil D, Margottin-Goguet F, Lacombe C, Mayeux P, Verdier F 2007 β-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood 109:5215-5222
27. Dos Santos GMA, Ten Broeke T, Strous GJ 2001 Growth hormone receptor ubiquitination, endocytosis, and degradation are independent of signal trans-duction via Janus kinase 2. J Biol Chem 276:32635-32641
28. Avrov K, Kazlauskas A 2003 The role of c-Src in platelet-derived growth factor a receptor internalization. Exp Cell Res 291:426-434
29. Khan EM, Heidinger JM, Levy M, Lisanti MP, Ravid T, Goldkorn T 2006 Epidermal growth factor receptor exposed to oxidative stress undergoes src-and caveolin-1-dependent perinuclear trafficking. J Biol Chem 281:14486-14493
30. 2-adrenergic receptor signaling to MAPK and in receptor internalization. J Biol Chem 279:21637-21642
31. Pelkmans L, Fava E, Grabner H, Hannus M, Habermann B, Krausz E, Zerial M 2005 Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436:78-86
32. Lajoie P, Nabi IR 2007 Regulation of raft-dependent endocytosis. J Cell Mol Med 11:644-653
33. Hitosugi T, Sato M, Sasaki K, Umezawa Y 2007 Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells. Cancer Res 67:8139-8148
34. Arcaro A, Aubert M, del Hierro MEE, Khanzada UK, Angelidou S, Tetley TD, Bittermann AG, Frame MC, Seckl MJ 2007 Critical role for lipid raft-associated Src kinases in activation of P13K-Akt signalling. Cell Signal 19:1081-1092
35. Schroeder MD, Symowicz J, Schuler LA 2002 Prolactin modulates cell cycle regulators in mammary tumor epithelial cells. Mol Endocrinol 16:45-57
36. Xie J, LeBaron MJ, Nevalainen MT, Rui H 2002 Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. J Biol Chem 277:14020-14030
37. Bain J, McLauchlan H, Elliott M, Cohen P 2003 The specificities of protein kinase inhibitors: an update. Biochem J371:199-204
38. Haan C, Kreis S, Margue C, Behrmann I 2006 Jaks and cytokine receptors - an intimate relationship. Biochem Pharmacol 72:1538-1546
39. Genty N, Paly J, Edery M, Kelly PA, Djiane J, Salesse R 1994 Endocytosis and degradation of prolactin and its receptor in Chinese hamster ovary cells stably transfected with prolactin receptor cDNA. Mol Cell Endocrinol 99:221-228
40. Djiane J, Delouis C, Kelly PA 982 Prolactin receptor turnover in explants of pseudopregnant rabbit mammary gland. Mol Cell Endocrinol 25:163-170
41. Wang XD, He K, Gerhart M, Huang Y, Jiang J, Paxton RJ, Yang SS, Lu CS, Menon RK, Black RA, Baumann G, Frank SJ 2002 Metalloprotease-mediated GH receptor proteolysis and GHBP shedding: determination of extracellular domain stem region cleavage site. J Biol Chem 277:50510-50519
42. Di Paolo G, De Camilli P 2006 Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651-657
43. Mayor S, Pagano RE 2007 Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8:603-612
44. Smart EJ, Ying YS, Mineo C, Anderson RG 1995 A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 92:10104-10108
45. Kim YN, Bertics PJ 2002 The endocytosis-linked protein dynamin associates with caveolin-1 and is tyrosine phosphorylated in response to the activation of a noninternalizing epidermal growth factor receptor mutant. Endocrinology 143:1726-1731
46. 2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J Biol Chem 274:1185-1188
47. Shajahan AN, Timblin BK, Sandoval R, Tiruppathi C, Malik AB, Minshall RD 2004 Role of Src-induced dynamin-2 phosphorylation in caveolae-medi-ated endocytosis in endothelial cells. J Biol Chem 279:20392-20400
48. Lu J-C, Scott P, Strous GJ, Schuler LA 2002 Multiple internalization motifs differentially used by prolactin receptor isoforms mediate similar endocytic pathways. Mol Endocrinol 16:2515-2527
49. Ungewickell EJ, Hinrichsen L 2007 Endocytosis: clathrin-mediated membrane budding. Curr Opin Cell Biol 19:417-425
50. Golub T, Wacha S, Caroni P 2004 Spatial and temporal control of signaling through lipid rafts. Curr Opin Neurobiol 14:542-550
51. Mukherjee S, Maxfield FR 2004 Membrane domains. Annu Rev Cell Dev Biol 20:839-866
52. Orlandi PA, Fishman PH 1998 Filipin-dependent inhibition of cholera toxin: Evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 141:905-915
53. Nichols BJ, Lippincott-Schwartz J 2001 Endocytosis without clathrin coats. Trends Cell Biol 11:406-412
54. Williams TM, Lisanti MP 2005 Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288:C494-C506
55. Dahl ME, Arai K, Watanabe S 2000 Association of Lyn tyrosine kinase to the GM-CSF and IL-3 receptor common βc subunit and role of Src tyrosine kinases in DNA synthesis and anti-apoptosis. Genes Cells 5:143-153
56. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL 2003 Distinct en-docytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 5:410-421
57. Kline JB, Clevenger CV 2001 Identification and characterization of the prolactin-binding protein in human serum and milk. J Biol Chem 276:24760-24766
58. Richardson DS, Lai AZ, Mulligan LM 2006 RET ligand-induced internaliza-tion and its consequences for downstream signaling. Oncogene 25:3206-3211
59. Gorska MM, Cen O, Liang Q, Stafford SJ, Alam R 2006 Differential regulation ofinterleukin 5-stimulated signaling pathways by dynamin. J Biol Chem 281:14429-14439
60. Fresno Vara JA, Caceres MA, Silva A, Martin-Perez J 2001 Src family kinases are required for prolactin induction of cell proliferation. Mol Biol Cell 12:2171-2183
61. Laszlo GS, Nathanson NM 2003 Src family kinase-independent signal trans-duction and gene induction by leukemia inhibitory factor. J Biol Chem 278:27750-27757
62. Allevato G, Billestrup N, Goujon L, Galsgaard ED, Norstedt G, Postel-Vinay M-C, KellyPA, Nielsen JH 1995 Identification ofphenylalanine 346 in the rat growth hormone receptor as being critical for ligand-mediated internalization and down-regulation. J Biol Chem 270:17210-17214
63. Maamra M, Finidori J, Von Laue S, Simon S, Justice S, Webster J, Dower S, Ross R 1999 Studies with a growth hormone antagonist and dual-fluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform, is very rapidly internalized independent of Jak2-Stat5 signaling. J Biol Chem 274:14791-14798
64. Johnson FM, Gallick GE 2007 SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy. Anticancer Agents Med Chem 7:651-659
65. Finn RS 2008 Targeting Src in breast cancer. Ann Oncol 19:1379-1386
66. Hiscox S, Nicholson RI 2008 Src inhibitors in breast cancer therapy. Expert Opin Ther Targets 12:757-767
67. Brockman JL, Schroeder MD, Schuler LA 2002 Prolactin activates the cyclin D1 promoter via the JAK2-STAT pathway. Mol Endocrinol 16:774-784
68. Lavie Y, Fiucci G, Liscovitch M 1998 Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J Biol Chem 273:32380-32383